Diabetes
Conference Coverage
Tirzepatide lowers weight across all groups with obesity
The antiobesity medication semaglutide “took things up one big notch, and now tirzepatide is up a little notch above that,” one expert said.
Conference Coverage
If a saphenous graft is available, treat limb threatening ischemia surgically
Surgery beats endovascular treatment for limb threatening ischemia when saphenous grafts are an option, according to the BEST-CLI trial.
Conference Coverage
NAFLD patients with diabetes have higher fibrosis progression rate
Patients with type 2 diabetes had about a 2-year faster progression to fibrosis.
Conference Coverage
Triglyceride-lowering fails to show CV benefit in large fibrate trial
In the phase 3 PROMINENT trial, pemafibrate improved multiple lipid fractions in patients with type 2 diabetes, without any impact on...
News
Finerenone: ‘Striking’ cut in pneumonia, COVID-19 risks
Secondary analyses of the finerenone pivotal trials showed that the agent was linked with less infective pneumonia and blunted COVID-19 severity...
News
Yoga and other mind-body work good for diabetes control
Mind-body practices can control fasting blood glucose and A1c to a clinically significant extent, thus offering an effective complementary...
Conference Coverage
Drug repurposing ‘fast track’ to new medicines for obesity, diabetes
“We would like to progress some of these compounds to preclinical and clinical trials, but need to raise the funds for this expensive research.”...
News
Insulin rationing common, ‘surprising’ even among privately insured
Americans with private insurance are more likely to ration insulin than are those with public health insurance and the insulin-treated diabetes...
News
Diabetes becoming less potent risk factor for CVD events
Diabetes is no longer equal to cardiovascular disease as a risk factor for cardiovascular events, according to a population-based study in Ontario...
News
Finerenone benefits T2D across spectrum of renal function
Finerenone treatment of people with type 2 diabetes and albuminuria improved outcomes, compared with placebo regardless of renal functional status...